Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center

J Am Acad Dermatol. 2013 Oct;69(4):654-7. doi: 10.1016/j.jaad.2013.06.007.
No abstract available

Publication types

  • Evaluation Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Academic Medical Centers
  • Adult
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Dermatomyositis / diagnosis*
  • Dermatomyositis / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunoglobulins, Intravenous / therapeutic use*
  • Infusions, Intravenous
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Prednisone / therapeutic use
  • Retrospective Studies
  • Salvage Therapy*
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Immunoglobulins, Intravenous
  • Hydroxychloroquine
  • Prednisone
  • Methotrexate